Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России, Москва, Россия
Список исп. литературыСкрыть список 1. International Diabetes Federation. IDF diabetes atlas. 10th edition. 2021. Accessed November 10, 2021. https://diabetesatlas.org/ 2. Здравоохранение в России. 2019: Статистический сборник. М.: Росстат, 2019. https://rosstat.gov.ru/storage/mediabank/ Zdravoohran-2019.pdf [Healthcare in Russia. 2019: Statistical collection/Rosstat. Moscow, 2019. Accessed November 1, 2021. https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2019.pdf (in Russian).] 3. Дедов И.И., Шестакова М.В., Викулова О.К. и др. Атлас регистра сахарного диабета Российской Федерации. Статус 2018 г. Сахарный диабет. 2019; 22 (2S): 4–61. DOI: 10.14341/DM12208 [Dedov I.I., Shestakova M.V., Vikulova O.K. et al. Atlas of Diabetes Register in Russian Federation, status 2018. Diabetes mellitus. 2019; 22 (2S): 4–61. DOI: 10.14341/DM12208 (in Russian).] 4. Van Dieren S, Beulens JW, van der Schouw YT et al. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil 2010; 17 (Suppl. 1): S3-S8. DOI: 10.1097/01.hjr. 0000368191.86614.5a 5. Kengne AP, Patel A, Marre M et al. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J Cardiovasc Prev Rehabil 2011; 18 (3): 393–8. DOI: 10.1177/1741826710394270 6. De Rosa S, Arcidiacono B, Chiefari E et al. Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links. Front Endocrinol (Lausanne) 2018; 9: 2. DOI: 10.3389/fendo.2018.00002 7. Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations. Circulation 2016; 133 (24): 2459–502. DOI: 10.1161/circulationaha.116.022194 8. Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 2006; 368 (9529): 29–36. DOI: 10.1016/S0140-6736(06)68967-8 9. Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol 2018; 17 (1): 83. DOI: 10.1186/s12933-018-0728-6 10. Ballotari P, Ranieri SC, Luberto F et al. Sex differences in cardiovascular mortality in diabetics and nondiabetic subjects: a population-based study (Italy). Int J Endocrinol 2015; 2015: 914057. DOI:10.1155/2015/ 914057 11. Dal Canto E, Ceriello A, Rydén L et al. Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol 2019; 26 (Suppl. 2): 25–32. DOI: 10.1177/2047487319878371 12. Huang D, Refaat M, Mohammedi K et al. Macrovascular Complications in Patients with Diabetes and Prediabetes. Biomed Res Int 2017; 2017: 7839101. DOI:10.1155/2017/7839101 13. Emerging Risk Factors Collaboration, Sarwar N, Gao P et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375 (9733): 2215–22. DOI: 10.1016/S0140-6736(10)60484-9 14. Anand SS, Dagenais GR, Mohan V et al. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study. Eur J Prev Cardiol 2012; 19 (4): 755–64. DOI: 10.1177/1741826711409327 15. Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J 2013; 34 (31): 2436-43. DOI: 10.1093/eurheartj/ eht149 16. Huang D, Refaat M, Mohammedi K et al. Macrovascular Complications in Patients with Diabetes and Prediabetes. Biomed Res Int 2017; 2017: 7839101. DOI:10.1155/2017/7839101 17. Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 2010; 106 (8): 1319–31. DOI: 10.1161/CIRCRESAHA.110.217117 18. Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations. Circulation 2016; 133 (24): 2459–502. DOI: 10.1161/circulationaha.116.022194 19. Zhang Y, Hu G, Yuan Z, Chen L. Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis. PLoS One 2012; 7 (8): e42551. DOI: 10.1371/journal.pone.0042551 20. Cavender MA, Scirica BM, Raz I et al. Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c. Am J Med 2016; 129 (3): 340.e1-340.e3408. DOI: 10.1016/j.amjmed.2015.09.022 21. Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321 (7258): 405–12. DOI:10.1136/bmj.321.7258.405 22. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 2010; 33 (6):1389–94. DOI: 10.2337/dc09-2082 23. Laitinen T, Lyyra-Laitinen T, Huopio H et al. Electrocardiographic alterations during hyperinsulinemic hypoglycemia in healthy subjects. Ann Noninvasive Electrocardiol 2008; 13 (2): 97–105. DOI:10.1111/j. 1542-474X.2008.00208.x 24. Gill GV, Woodward A, Casson IF, Weston PJ. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes – the 'dead in bed' syndrome revisited. Diabetologia 2009; 52 (1): 42–5. DOI: 10.1007/s00125-008-1177-7 25. Robinson RT, Harris ND, Ireland RH et al. Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes 2003; 52 (6): 1469–74. DOI: 10.2337/diabetes.52.6.1469 26. Perros P, Deary IJ, Sellar RJ et al. Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 1997; 20 (6): 1013–8. DOI: 10.2337/diacare.20.6.1013 27. Whitmer RA, Karter AJ, Yaffe K et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009; 301 (15): 1565–72. DOI: 10.1001/jama.2009.460 28. de Galan BE, Zoungas S, Chalmers J et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia 2009; 52 (11): 2328–36. DOI: 10.1007/ s00125-009-1484-7 29. Yun JS, Park YM, Han K et al. Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study. Cardiovasc Diabetol 2019; 18 (1): 103. DOI: 10.1186/s12933-019-0909-y 30. Paulus WJ, Dal Canto E. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction. JACC Heart Fail 2018; 6 (1): 1–7. DOI: 10.1016/j.jchf.2017.07.012 31. Umpierrez GE, P Kovatchev B. Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes. Am J Med Sci 2018; 356 (6): 518–27. DOI: 10.1016/j.amjms.2018.09.010 32. Scott ES, Januszewski AS, O'Connell R et al. Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study. J Clin Endocrinol Metab 2020; 105 (10): dgaa361. DOI: 10.1210/clinem/dgaa361 33. Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol 2019; 7 (3): 221–30. DOI: 10.1016/S2213-8587(18)30136-0 34. Huang D, Refaat M, Mohammedi K et al. Macrovascular Complications in Patients with Diabetes and Prediabetes. Biomed Res Int 2017; 2017: 7839101. DOI: 10.1155/2017/7839101 35. Nauck MA, Haastert B, Trautner C et al. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment. Diabetologia 2014; 57 (5): 868–77. DOI: 10.1007/s00125-014-3168-1 36. Clar C, Barnard K, Cummins E et al.; Aberdeen Health Technology Assessment Group. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess 2010; 14 (12): 1–140. DOI: 10.3310/hta14120 37. Дедов И.И., Шестакова М.В., Майоров А.Ю. и др. Сахарный диабет 2-го типа у взрослых. Сахарный диабет. 2020; 23 (2S): 4–102. DOI: 10.14341/DM12507 [Dedov I.I., Shestakova M.V., Mayorov A.Yu. et al. Diabetes mellitus type 2 in adults. Diabetes mellitus. 2020; 23 (2S): 4–102. DOI: 10.14341/ DM12507 (in Russian).] 38. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019; 42 (Suppl. 1): S13–S28. DOI: 10.2337/dc19-S002 39. Cosentino F, Grant PJ, Aboyans V et al. Рекомендации ЕSC/EASD по сахарному диабету, предиабету и сердечно-сосудистым заболеваниям, 2019 г. Российский кардиологический журнал. 2020; 25 (4): 3839. DOI: 10.15829/1560-4071-2020-3839 [Cosentino F, Grant PJ, Aboyans V et al. Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds/Leeds Teaching Hospitals NHS Trust, LIGHT Laboratories, Clarendon Way. Russian Journal of Cardiology. 2020; 25 (4): 3839. DOI: 10.15829/1560-4071-2020-3839 (in Russian).] 40. Bailey TS, Wallace JF, Pardo S et al. Accuracy and User Performance Evaluation of a New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device. J Diabetes Sci Technol 2017; 11 (4): 736–43. DOI:10.1177/1932296816680829